Literature DB >> 17536107

PET measurements of myocardial glucose metabolism with 1-11C-glucose and kinetic modeling.

Pilar Herrero1, Zulfia Kisrieva-Ware, Carmen S Dence, Bruce Patterson, Andrew R Coggan, Dong-Ho Han, Yosuke Ishii, Paul Eisenbeis, Robert J Gropler.   

Abstract

UNLABELLED: The aim of this study was to investigate whether compartmental modeling of 1-(11)C-glucose PET kinetics can be used for noninvasive measurements of myocardial glucose metabolism beyond its initial extraction.
METHODS: 1-(11)C-Glucose and U-(13)C-glucose were injected simultaneously into 22 mongrel dogs under a wide range of metabolic states; this was followed by 1 h of PET data acquisition. Heart tissue samples were analyzed for (13)C-glycogen content (nmol/g). Arterial and coronary sinus blood samples (ART/CS) were analyzed for glucose (mumol/mL), (11)C-glucose, (11)CO(2), and (11)C-total acidic metabolites ((11)C-lactate [LA] + (11)CO(2)) (counts/min/mL) and were used to calculate myocardial fractions of (a) glucose and 1-(11)C-glucose extractions, EF(GLU) and EF((11)C-GLU); (b) (11)C-GLU and (11)C-LA oxidation, OF((11)C-GLU) and OF((11)C-LA); (c) (11)C-glycolsysis, GCF((11)C-GLU); and (d) (11)C-glycogen content, GNF((11)C-GLU). On the basis of these measurements, a compartmental model (M) that accounts for the contribution of exogenous (11)C-LA to myocardial (11)C activity was implemented to measure M-EF(GLU), M-GCF(GLU), M-OF(GLU), M-GNF(GLU), and the fraction of myocardial glucose stored as glycogen M-GNF(GLU)/M-EF(GLU)).
RESULTS: ART/CS data showed the following: (a) A strong correlation was found between EF((11)C-GLU) and EF(GLU) (r = 0.92, P < 0.0001; slope = 0.95, P = not significantly different from 1). (b) In interventions with high glucose extraction and oxidation, the contribution of OF((11)C-GLU) to total oxidation was higher than that of OF((11)C-LA) (P < 0.01). In contrast, in interventions in which glucose uptake and oxidation were inhibited, OF((11)C-LA) was higher than OF((11)C-GLU) (P < 0.05). (c) A strong correlation was found between GNF((11)C-GLU)/EF(GLU) and direct measurements of fractional (13)C-glycogen content, (r = 0.96, P < 0.0001). Model-derived PET measurements of M-EF(GLU), M-GCF(GLU), and M-OF(GLU) strongly correlated with EF(GLU) (slope = 0.92, r = 0.95, P < 0.0001), GCF((11)C-GLU) (slope = 0.79, r = 0.97, P < 0.0001), and OF((11)C-GLU) (slope = 0.70, r = 0.96, P < 0.0001), respectively. M-GNF(GLU)/M-EF(GLU) strongly correlated with fractional (13)C-content (r = 0.92, P < 0.0001).
CONCLUSION: Under nonischemic conditions, it is feasible to measure myocardial glucose metabolism noninvasively beyond its initial extraction with PET using 1-(11)C-glucose and a compartmental modeling approach that takes into account uptake and oxidation of secondarily labeled exogenous (11)C-lactate.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17536107     DOI: 10.2967/jnumed.106.037598

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  15 in total

Review 1.  Imaging myocardial metabolic remodeling.

Authors:  Robert J Gropler; Rob S B Beanlands; Vasken Dilsizian; E Douglas Lewandowski; Flordeliza S Villanueva; Maria Cecilia Ziadi
Journal:  J Nucl Med       Date:  2010-05-01       Impact factor: 10.057

2.  Sex and type 2 diabetes: obesity-independent effects on left ventricular substrate metabolism and relaxation in humans.

Authors:  Linda R Peterson; Ibrahim M Saeed; Janet B McGill; Pilar Herrero; Kenneth B Schechtman; Ratnasiri Gunawardena; Carol L Recklein; Andrew R Coggan; Amanda J DeMoss; Carmen S Dence; Robert J Gropler
Journal:  Obesity (Silver Spring)       Date:  2011-08-04       Impact factor: 5.002

Review 3.  SPECT and PET in ischemic heart failure.

Authors:  George Angelidis; Gregory Giamouzis; Georgios Karagiannis; Javed Butler; Ioannis Tsougos; Varvara Valotassiou; George Giannakoulas; Nikolaos Dimakopoulos; Andrew Xanthopoulos; John Skoularigis; Filippos Triposkiadis; Panagiotis Georgoulias
Journal:  Heart Fail Rev       Date:  2017-03       Impact factor: 4.214

Review 4.  Cardiac molecular imaging to track left ventricular remodeling in heart failure.

Authors:  Jamshid Shirani; Amitoj Singh; Sahil Agrawal; Vasken Dilsizian
Journal:  J Nucl Cardiol       Date:  2016-08-01       Impact factor: 5.952

5.  Weight Loss Affects Intramyocardial Glucose Metabolism in Obese Humans.

Authors:  Michael J Madigan; Susan B Racette; Andrew R Coggan; Richard I Stein; Lena M McCue; Robert J Gropler; Linda R Peterson
Journal:  Circ Cardiovasc Imaging       Date:  2019-07-29       Impact factor: 7.792

Review 6.  Radionuclide imaging of myocardial metabolism.

Authors:  Linda R Peterson; Robert J Gropler
Journal:  Circ Cardiovasc Imaging       Date:  2010-03       Impact factor: 7.792

7.  PET detection of the impact of dobutamine on myocardial glucose metabolism in women with type 1 diabetes mellitus.

Authors:  Pilar Herrero; Janet McGill; Donna S Lesniak; Carmen S Dence; Shalonda W Scott; Zulfia Kisrieva-Ware; Robert J Gropler
Journal:  J Nucl Cardiol       Date:  2008 Nov-Dec       Impact factor: 5.952

Review 8.  Imaging and modeling of myocardial metabolism.

Authors:  Sebastian Obrzut; Neema Jamshidi; Afshin Karimi; Ulrika Birgersdotter-Green; Carl Hoh
Journal:  J Cardiovasc Transl Res       Date:  2010-02-25       Impact factor: 4.132

9.  Measurement of myocardial fatty acid esterification using [1-11C]palmitate and PET: comparison with direct measurements of myocardial triglyceride synthesis.

Authors:  Andrew R Coggan; Zulfia Kisrieva-Ware; Carmen S Dence; Paul Eisenbeis; Robert J Gropler; Pilar Herrero
Journal:  J Nucl Cardiol       Date:  2009-05-29       Impact factor: 5.952

10.  Time course of alterations in myocardial glucose utilization in the Zucker diabetic fatty rat with correlation to gene expression of glucose transporters: a small-animal PET investigation.

Authors:  Kooresh I Shoghi; Robert J Gropler; Terry Sharp; Pilar Herrero; Nicole Fettig; Yi Su; Mayurranjan S Mitra; Attila Kovacs; Brian N Finck; Michael J Welch
Journal:  J Nucl Med       Date:  2008-07-16       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.